Vinoth Kumar Megraj Khandelwal
Overview
Explore the profile of Vinoth Kumar Megraj Khandelwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klionsky D, Abdel-Aziz A, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al.
Autophagy
. 2021 Feb;
17(1):1-382.
PMID: 33634751
In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our...
2.
Marslin G, Revina A, Khandelwal V, Balakumar K, Sheeba C, Franklin G
Colloids Surf B Biointerfaces
. 2019 Feb;
177:282-283.
PMID: 30769229
No abstract available.
3.
Palanivel S, Zhurina A, Doan P, Chandraseelan J, Khandelwal V, Zubkov F, et al.
Saudi Pharm J
. 2018 Mar;
26(3):430-436.
PMID: 29556135
Arylhydrazones of active methylene compounds (AHAMCs) are potent chemotherapy agents for the cancer treatment. AHAMCs enhance the apoptotic cell death and antiproliferation properties in cancer cells. In this study, a...
4.
Marslin G, Siram K, Liu X, Khandelwal V, Xiaolei S, Xiang W, et al.
Molecules
. 2017 Nov;
22(11).
PMID: 29165384
Albendazole (ABZ) is an antihelminthic drug used for the treatment of several parasitic infestations. In addition to this, there are reports on the anticancer activity of ABZ against a wide...
5.
Marslin G, Revina A, Khandelwal V, Balakumar K, Sheeba C, Franklin G
Colloids Surf B Biointerfaces
. 2015 May;
132:62-70.
PMID: 26005932
The rise of bacterial resistance against important drugs threatens their clinical utility. Fluoroquinones, one of the most important classes of contemporary antibiotics has also reported to suffer bacterial resistance. Since...
6.
Marslin G, Revina A, Khandelwal V, Balakumar K, Prakash J, Franklin G, et al.
Int J Nanomedicine
. 2015 May;
10:3163-70.
PMID: 25995626
Clinical effectiveness of imatinib mesylate in cancer treatment is compromised by its off-target cardiotoxicity. In the present study, we have developed physically stable imatinib mesylate-loaded poly(lactide-co-glycolide) nanoparticles (INPs) that could...
7.
Gregory M, Khandelwal V, Mary R, Kalaichelvan V, Palanivel V
Chin J Nat Med
. 2014 Mar;
12(2):126-30.
PMID: 24636063
Aim: This study was aimed at evaluating the anti-diabetic activity of the ethanol and aqueous extracts of the leaf material of Barringtonia acutangula in a diabetic animal model. Methods: The...
8.
Ravingerova T, carnicka S, Nemcekova M, Ledvenyiova V, Adameova A, Kelly T, et al.
Can J Physiol Pharmacol
. 2012 Jul;
90(8):1135-44.
PMID: 22809038
Peroxisome proliferator-activated receptors (PPAR) regulate the expression of genes involved in lipid metabolism, energy production, and inflammation. Their role in ischaemia-reperfusion (I/R) is less clear, although research indicates involvement of...
9.
Ramanlal Chaudhari K, Kumar A, Khandelwal V, Ukawala M, Manjappa A, Mishra A, et al.
J Control Release
. 2011 Dec;
158(3):470-8.
PMID: 22146683
In spite of good research in drug delivery, bone targeting remains largely unexplored. Even some of the bone diseases are seldom cured just because of poor distribution of drug at...
10.
Khandelwal V, Balaraman R, Pancza D, Ravingerova T
Evid Based Complement Alternat Med
. 2010 Oct;
2011.
PMID: 20953394
Hemidesmus indicus (L.) R. Br. (HI) and Hibiscus rosa-sinensis L. (HRS) are widely used traditional medicine. We investigated cardioprotective effects of these plants applied for 15 min at concentrations of...